Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial An accurate risk model is critical for risk-stratified cancer care and ...
Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found. Daily aspirin reduced by 55% the risk of cancer recurrence in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback